Evidence for ProTα-TLR4/MD-2 binding: molecular dynamics and gravimetric assay studies. (July 2015)
- Record Type:
- Journal Article
- Title:
- Evidence for ProTα-TLR4/MD-2 binding: molecular dynamics and gravimetric assay studies. (July 2015)
- Main Title:
- Evidence for ProTα-TLR4/MD-2 binding: molecular dynamics and gravimetric assay studies
- Authors:
- Omotuyi, Olaposi
Matsunaga, Hayato
Ueda, Hiroshi - Abstract:
- <abstract> <title> <x xml:space="preserve">Abstract</x> </title> <p> <bold> <italic>Objective:</italic> </bold> During preconditioning, lipopolysaccharide (LPS) selectively activates TLR4/MD-2/Toll/IL-1 receptor-domain-containing adaptor inducing IFN-β (TRIF) pathway instead of pro-inflammatory myeloid differentiation protein-88 (MyD88)/MyD88-adaptor-like protein (MAL) pathway. Extracellular prothymosin alpha (ProTα) is also known to selectively activate the TLR4/MD2/TRIF–IRF3 pathway in certain diseased conditions. In the current study, biophysical evidence for ProTα/TLR4/MD-2 complex formation and its interaction dynamics have been studied.</p> <p> <bold> <italic>Research design and methods:</italic> </bold> Gravimetric assay was used to investigate ProTα/TLR4/MD-2 complex formation while molecular dynamics (MD) simulation was used to study its interaction dynamics.</p> <p> <bold> <italic>Results:</italic> </bold> Through electrostatic interaction, full-length ProTα (F-ProTα) C-terminal peptide (aa 91 – 111) superficially interacts with similar TLR4/MD-2 (K<sub>D</sub> = 273.36 nm vs 16.07 μg/ml [LPS]) conformation with LPS at an overlapping three-dimensional space while F-ProTα is hinged to the TLR4 scaffold by one-amino acid shift-Mosoian domain (aa-51 – 90). Comparatively, F-ProTα better stabilizes MD-2 metastable states transition and mediates higher TLR4/MD-2 interaction than LPS.</p> <p> <bold> <italic>Conclusions: </italic> </bold>ProTα via its C-terminal peptide<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <p> <bold> <italic>Objective:</italic> </bold> During preconditioning, lipopolysaccharide (LPS) selectively activates TLR4/MD-2/Toll/IL-1 receptor-domain-containing adaptor inducing IFN-β (TRIF) pathway instead of pro-inflammatory myeloid differentiation protein-88 (MyD88)/MyD88-adaptor-like protein (MAL) pathway. Extracellular prothymosin alpha (ProTα) is also known to selectively activate the TLR4/MD2/TRIF–IRF3 pathway in certain diseased conditions. In the current study, biophysical evidence for ProTα/TLR4/MD-2 complex formation and its interaction dynamics have been studied.</p> <p> <bold> <italic>Research design and methods:</italic> </bold> Gravimetric assay was used to investigate ProTα/TLR4/MD-2 complex formation while molecular dynamics (MD) simulation was used to study its interaction dynamics.</p> <p> <bold> <italic>Results:</italic> </bold> Through electrostatic interaction, full-length ProTα (F-ProTα) C-terminal peptide (aa 91 – 111) superficially interacts with similar TLR4/MD-2 (K<sub>D</sub> = 273.36 nm vs 16.07 μg/ml [LPS]) conformation with LPS at an overlapping three-dimensional space while F-ProTα is hinged to the TLR4 scaffold by one-amino acid shift-Mosoian domain (aa-51 – 90). Comparatively, F-ProTα better stabilizes MD-2 metastable states transition and mediates higher TLR4/MD-2 interaction than LPS.</p> <p> <bold> <italic>Conclusions: </italic> </bold>ProTα via its C-terminal peptide (aa 91 – 111) exhibits <italic>in vitro</italic> biophysical contact with TLR4/MD-2 complex conformation recognized by LPS at overlapping LPS-binding positions.</p> </abstract> … (more)
- Is Part Of:
- Expert opinion on biological therapy. Volume 15:Number 1(2015:Jan.)
- Journal:
- Expert opinion on biological therapy
- Issue:
- Volume 15:Number 1(2015:Jan.)
- Issue Display:
- Volume 15, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 15
- Issue:
- 1
- Issue Sort Value:
- 2015-0015-0001-0000
- Page Start:
- 223
- Page End:
- 229
- Publication Date:
- 2015-07
- Subjects:
- Gene therapy -- Periodicals
Protein drugs -- Periodicals
Peptide drugs -- Periodicals
Immunotherapy -- Periodicals
Drug delivery systems -- Periodicals
615.5 - Journal URLs:
- http://informahealthcare.com/journal/ebt ↗
http://www.ashley-pub.com/loi/ebt ↗
http://www.tandfonline.com/toc/iebt20/current ↗
http://informahealthcare.com ↗
http://miranda.ashley-pub.com/vl=2623054/cl=18/nw=1/rpsv/journal/journal1_home.htm ↗ - DOI:
- 10.1517/14712598.2015.1005597 ↗
- Languages:
- English
- ISSNs:
- 1471-2598
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002940
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3904.xml